Article Information
History
- September 25, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Saverio Caini1,*,
- Adam Meijer2,
- Marta C. Nunes3,4,5,
- Laetitia Henaff4,
- Malaika Zounon4,
- Bronke Boudewijns1,
- Marco Del Riccio1,6 and
- John Paget1
- 1Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands
- 2National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- 3Center of Excellence in Respiratory Pathogens (CERP), Hospices Civils de Lyon, Lyon, France
- 4Centre International de Recherche en Infectiologie (Team Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID)), Inserm U1111, CNRS UMR5308, ENS de Lyon, Université Claude Bernard, Lyon 1, Lyon, France
- 5South African Medical Research Council, Vaccines & Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 6Department of Health Sciences, University of Florence, Florence, Italy
- ↵*Corresponding author, Saverio Caini Netherlands Institute for Health Services Research (Nivel) Otterstraat 118, 3513 CR Utrecht, the Netherlands. Email address
: s.caini{at}nivel.nl
Posted September 25, 2023.
Is influenza B/Yamagata extinct and what public health implications could this have? An updated literature review and comprehensive assessment of global surveillance databases
